A Study of Music Therapy for Anxiety in People With Cancer
ConditionCancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The researchers are doing this study to compare two different music-based treatment approaches and see if one may work better to reduce anxiety. The researchers will also study whether these music-based treatment approaches help people feel socially connected and change how they cope with anxiety, and whether these changes are linked to lower anxiety levels. Both approaches use music-based activities to treat anxiety. One of the approaches uses an artificial intelligence (AI)-powered song creation platform to write songs with a music therapist. The other approach involves music listening exercises and music-based discussions with research staff, during which you will learn about music culture and history.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients must have a pathologically confirmed advanced cancer diagnosis: stage III or IV lung cancer; any stage pancreatic cancer, unresectable cholangiocarcinoma, unresectable liver cancer, unresectable ampullary or peri-ampullary cancer, or other stage IV gastrointestinal cancer; stage III or IV ovarian or fallopian tube cancers or other stage IV gynecologic cancer; stage IV breast cancer; stage III testicular cancer or any stage IV genitourinary cancer; stage IV sarcoma; stage IV melanoma; stage IV endocrine cancer; lymphoma, myeloma, or leukemia
Currently receiving oncological treatment
Age ≥ 18; English speaking
Ambulatory as indicated by a Karnofsky performance score of 60 or higher
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
AI-Assisted Collaborative Songwriting (ARTIST) Intervention
Other interventionPatients will complete outcome measures of anxiety, social-cognitive outcomes, and co-morbid symptoms at baseline, week 4, week 8, week 16, and week 26.
Time and attention matched-music listening (TAME)
Other interventionTAME control will involve Collaborative Institutional Training Initiative (CITI)-trained research staff guiding participants through passive music listening exercises. This control group is designed to match therapist attention and contact time of ARTIST, as well as control for music engagement unrelated to the active ingredient of ARTIST. Patients will complete outcome measures of anxiety, social-cognitive outcomes, and co-morbid symptoms at baseline, week 4, week 8, week 16, and week 26.
Treatment groups
240 Participants
are divided into 2 treatment groupsGroup A: AI-assisted collaborative songwriting (ARTIST)Experimental treatment 1 intervention
Group B: Time and attention matched-music listening (TAME)Active comparator 1 intervention
Trial outcomes
Primary outcomes
1
anxiety change
anxiety reduction at week 26 being the primary endpoint greater reduction in the Hospital Anxiety and Depression Scale (HADS) anxiety subscale
Time frame
26 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Memorial Sloan Kettering Cancer Center
Lead sponsor
Drexel University
Collaborator
Source ClinicalTrials.gov